Medical Therapy and Recurrent Ischemic Events in High Risk Patients Surviving their Myocardial Infarction for at Least 12 Months: Comparison of Patients with ST Elevation Versus Non-ST Elevation Myocardial Infarction [0.03%]
从急性心肌梗死后存活至少一年的高危患者中比较ST段抬高与非ST段抬高型心肌梗死患者的复发缺血事件和药物治疗状况
Uwe Zeymer,Katrin Riedel,Michael Hahn
Uwe Zeymer
Introduction: Data about treatments and recurrent ischemic events in patients surviving their most recent myocardial infarction event-free for at least 12 months are scarce. ...
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study [0.03%]
抗凝患者的分析管理可能对临床结果产生重大影响：一项随访研究
Vincenzo De Iuliis,Sebastiano Ursi,Gianfranco Vitullo et al.
Vincenzo De Iuliis et al.
Introduction: Oral anticoagulant therapy, such as vitamin K antagonists (VKAs), is prominent for the prevention of cerebral ischemic stroke or systemic embolism and all-cause mortality in patients with atrial fibrillation...
Iain M Dykes
Iain M Dykes
Exosomes are small, extracellular membrane-bound particles that mediate intercellular transport of a cytosolic cargo. Exosomal transfer of micro-RNA can modify gene expression in targeted cells. Exosome-based endocrine/paracrine signaling h...
Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS II Study in Egypt [0.03%]
中东地区高胆固醇治疗不足的中心调查：埃及CEPHEUS II研究结果
Ashraf Reda,Alaa Etman,Ali Abdel-Rahim et al.
Ashraf Reda et al.
Introduction: As part of the CEPHEUS study, CEPHEUS I was conducted in 2010 and 2011 in Cairo and then the CEPHEUS II study was carried out in Alexandria and Delta Regions in Egypt between April 2014 and August 2015 to de...
High-risk Trans-Catheter Aortic Valve Replacement in a Failed Freestyle Valve with Low Coronary Height: A Case Report [0.03%]
低冠状动脉高度弗雷斯特瓣膜失效的经导管主动脉瓣膜置换术：一例高危患者的临床病例报告
Ashkan Karimi,Negiin Pourafshar,George Dibu et al.
Ashkan Karimi et al.
A 55-year-old male with a history of two prior cardiac surgeries presented with decompensated heart failure due to severe bioprosthetic aortic valve insufficiency. A third operation was viewed prohibitively high risk and valve-in-valve tran...
Xiaoshen Zhang,Han Zhang,Yuxia Ma et al.
Xiaoshen Zhang et al.
Hypertension is one of the most significant and consistent risk factors for many cardiovascular diseases. The global prevalence of hypertension has dramatically increased over recent years. Life-style and genetic factors are generally consi...
Inappropriate ICD Discharge Related to Electrical Muscle Stimulation in Chiropractic Therapy: A Case Report [0.03%]
肌电刺激 chiropractic 治疗中不适当的 ICD 出院相关性：病例报告
Abhishek Shenoy,Abhishek Sharma,Firehiwot Achamyeleh
Abhishek Shenoy
Implantable cardioverter defibrillators (ICDs) have been shown to reduce mortality in high-risk patients. Despite several advances in programming ICDs, inappropriate shocks persist and continue to be psychologically and physically disturbin...
Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial [0.03%]
培哚普利/吲达帕胺/氨氯地平单片固定剂量联合制剂治疗难治性高血压患者的一项随机对照试验
Sergey V Nedogoda,Vesna J Stojanov
Sergey V Nedogoda
Introduction: Patients with hypertension often require a combination of three antihypertensive agents to achieve blood pressure control, but very few single-pill triple combinations are available. The aim of this study wa...
Subclinical Right Ventricular Dysfunction in Patients with Severe Aortic Stenosis: A Retrospective Case Series [0.03%]
重度主动脉瓣狭窄患者右心室功能不全的回顾性病例系列研究
Dagmar F Hernandez-Suarez,Angel López-Candales
Dagmar F Hernandez-Suarez
Introduction: There is scarce information about right ventricle (RV) function in patients with secondary pulmonary hypertension (PH) undergoing transcatheter aortic valve implantation (TAVI). We aim to identify possible R...
The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article [0.03%]
替格瑞洛在经皮冠状动脉介入治疗中应用的利与弊——文献综述
Constantinos Andreou,Christos Maniotis,Michael Koutouzis
Constantinos Andreou
Bivalirudin is a direct thrombin inhibitor used during percutaneous coronary intervention (PCI). Treatment with bivalirudin compared to heparin plus glycoprotein IIb/IIIa inhibitors (GPI) reduced bleeding complications, but resulted in high...